Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2001 Dec;94(3):255-260.
doi: 10.1016/S0304-3959(01)00358-X.

Botulinum toxin A for the treatment of chronic neck pain

Anthony H Wheeler  1 , Paula Goolkasian, Stephanie S Gretz
Affiliations
Clinical Trial

Botulinum toxin A for the treatment of chronic neck pain

Anthony H Wheeler et al. Pain. 2001 Dec.

Abstract

A clinical study tested the therapeutic efficacy of Botulinum toxin A (BTXA) when injected into symptomatic neck muscles after one injection session. Patients with chronic neck pain were randomly assigned to receive either a high dose of an active treatment or an injection of the same volume of normal saline. Patients were compared for 4 months using a comprehensive set of outcome measures that included the Neck Pain and Disability Scale (Spine 24 (1999) 1290) and pressure algometry (Arch Phys Med Rehabil 67 (1986) 406; Pain 30 (1987) 115; Clin J Pain 2 (1987) 207). Analyses were consistent in showing significant benefits from the injection session; however, the effects were not specific to the group treated with BTXA. Both treatment and control groups showed a significant decline in pain and disability across time and an increased ability to withstand pressure on trigger points. The heavy incidence of adverse events in the treatment group may partly explain the absence of a treatment effect specific to BTXA. The results show that a single dose treatment without physical therapy is not effective for chronic neck pain.

PubMed Disclaimer

References

    1. Bovim J, Schrader H, Sand T. Neck pain in the general population. Spine. 1994;19:1307-1309.
    1. Cheshire WP, Abashjan SW, Mann JD. Botulinum toxin in the treatment of myofascial pain syndrome. Pain. 1994;59:65-69.
    1. Drewes AM, Jennum P. Epidemiology of myofascial pain, low back pain, morning stiffness and sleep related complaints in the general population. J Musculoskeletal Pain. 1995;3(Suppl):68.
    1. Fischer AA. Pressure tolerance over muscles and bones in normal subjects. Arch Phys Med Rehabil. 1986;67:406-409.
    1. Fischer AA. Pressure algometry over normal muscle: standard (145) values, validity and reproducibility of pressure threshold. Pain. 1987;30:115-126.

Publication types

Substances